ZBH Filing
4Filing Date: Jul 2, 2026

ZIMMER BIOMET HOLDINGS, INC. (ZBH) · Insider Trading (Form 4) SEC Filing

Statement of Changes in Beneficial Ownership

descriptionView SEC Filing
ACC: 0001910621-26-000008open_in_new
Total Value$0
Trades1
Insiders1

Transaction Details

Kurdikar Devdatt
Director·Direct
Grant · Acquire
Phantom Stock UnitsDerivative
Shares+180.32
Price$0.00
Total Value$0
Shares Owned After2.99K
Transaction DateJun 30, 2026
Footnotes ▸

The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. | The Conversion or Exercise Price of Derivative Security is 1-for-1. | Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. | Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

Post-Transaction Holdings

Kurdikar Devdatt
SecuritySharesChange
Phantom Stock Units2.99K+180.32 (6.42%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-06-30 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: ZIMMER BIOMET HOLDINGS, INC. (ZBH) CIK: 0001136869 --- Reporting Owner --- Name: Kurdikar Devdatt CIK: 0001910621 Role: Director --- Derivative Transactions --- [Transaction #1] Security: Phantom Stock Units Date: 2026-06-30 | Code: A (Grant or award) Shares: +180.323 | Price: $0.00 Shares Owned After: 2,990.182 | Ownership: D (Direct) Footnotes: [F1] The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. [F2] The Conversion or Exercise Price of Derivative Security is 1-for-1. [F3] Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. [F3] Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. --- Footnotes (Complete Index) --- F1: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. --- Signature --- /s/ /s/ Matthew R. St. Louis, Attorney-in-Fact for Devdatt Kurdikar (power of attorney previously filed) (2026-07-02)

keid analysis is for reference only and does not constitute investment advice.